Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Neurology

Navigating Seizures, Sleep, and Medical Care in Angelman Syndrome

At a Glance

Managing Angelman syndrome requires a multidisciplinary approach to address frequent seizures, severe sleep disturbances, and GI issues. Because children with AS are usually non-verbal, behavioral or sleep changes often signal physical discomfort requiring medical evaluation.

Managing Angelman syndrome (AS) often involves juggling multiple medical priorities at once. Because children with AS are frequently non-verbal, they may express physical discomfort—like reflux or a brewing seizure—through changes in behavior or sleep [1][2]. A multidisciplinary approach, involving neurologists, gastroenterologists, and sleep specialists, is the best way to ensure your child is comfortable and thriving [3].

Epilepsy and Seizure Management

Epilepsy is one of the most significant challenges in AS, affecting 80–90% of individuals [4][5]. Seizures typically begin before age three and can take many forms, including myoclonic (quick muscle jerks), atypical absence (staring spells), and tonic-clonic (stiffening and shaking) [6][7].

  • Medication Trends: While older drugs like valproic acid are effective, they can sometimes cause tremors or motor regressions in children with AS [6]. Newer medications such as levetiracetam, lamotrigine, and clobazam are often preferred due to better tolerability [6][8].
  • Dietary Therapy: The Low Glycemic Index Treatment (LGIT) is a specialized diet that focuses on stable blood sugar levels. It has been shown to be a highly effective alternative or supplement to medication, with some children achieving significant seizure reduction [9][10].
  • Safety Warning for Seizures: Certain anti-seizure medications, such as carbamazepine, oxcarbazepine, and vigabatrin, should generally be avoided in AS as they can exacerbate seizures or myoclonus. Additionally, common childhood illnesses and fevers can drastically lower the seizure threshold, requiring prompt management to prevent breakthrough seizures.

Navigating Sleep Disturbances

Up to 95% of individuals with AS experience sleep issues, including difficulty falling asleep and frequent night wakings [11][12]. This is partly due to a biological “diminished need for sleep” caused by the UBE3A protein deficiency [13][14].

  • Safety at Night: Because children with AS need very little sleep and are prone to wandering without an awareness of danger, many families utilize specialized enclosed safety beds to ensure the child remains safe during the night.
  • Melatonin: Exogenous melatonin is widely used to help regulate sleep-wake cycles and is generally considered safe for children with neurodevelopmental disorders [15][16].
  • Behavioral Strategies: Establishing strict sleep hygiene and behavioral routines is the first recommended step, though these may need to be adapted for the unique biological sleep drive of a child with AS [17][18].

Gastrointestinal (GI) Health

GI issues are “hidden” comorbidities that can cause significant distress. Constipation affects approximately 84% of children with AS, and GERD (gastroesophageal reflux disease) affects about 64% [19]. Another common issue is aerophagia (excessive air swallowing), which can contribute heavily to gastrointestinal distress and bloating.

  • The GI-Behavior Link: In non-verbal children, untreated constipation or reflux can lead to increased irritability, “happy” but agitated behavior, and worsened sleep [1].
  • Management: Treatment typically starts with lifestyle and diet changes, followed by osmotic laxatives for constipation or acid-blockers for GERD [20][21].

Long-Term Orthopedic and Bone Health

As children with AS grow into adulthood, new physical priorities emerge:

  • Scoliosis: About 30% of adults with AS develop scoliosis (curvature of the spine) [22].
  • Bone Density: There is a known risk for low bone density or osteoporosis, which affects about 20% of young adults with AS [22]. This risk may be increased by certain long-term seizure medications that affect Vitamin D metabolism [23]. Regular screening with DXA scans is the gold standard for monitoring bone health [24].

Common questions in this guide

Which seizure medications should be avoided in Angelman syndrome?
Certain anti-seizure medications, such as carbamazepine, oxcarbazepine, and vigabatrin, should generally be avoided in Angelman syndrome. These medications can actually exacerbate seizures or worsen myoclonic jerks.
What is the LGIT diet for Angelman syndrome?
The Low Glycemic Index Treatment (LGIT) is a specialized diet focused on maintaining stable blood sugar levels. It is a highly effective alternative or supplement to medication, with many children achieving significant seizure reduction.
Why do children with Angelman syndrome have so much trouble sleeping?
Up to 95% of individuals with Angelman syndrome experience sleep issues due to a biological diminished need for sleep caused by the UBE3A protein deficiency. This commonly leads to difficulty falling asleep and frequent night wakings.
How do GI issues like constipation affect behavior in Angelman syndrome?
Because children with Angelman syndrome are often non-verbal, they express physical discomfort from untreated constipation or acid reflux through behavior. This can look like increased irritability, an agitated 'happy' demeanor, or worsened sleep.
How often should bone health be monitored in adults with Angelman syndrome?
Adults with Angelman syndrome have an increased risk of developing low bone density or osteoporosis, especially if they take certain seizure medications long-term. Regular screening with a DXA scan is the gold standard for monitoring their bone health.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which seizure medications are currently preferred for children with Angelman syndrome, and are there any we should specifically avoid due to the risk of worsening myoclonus?
  2. 2.Is my child a candidate for the Low Glycemic Index Treatment (LGIT) to help manage their seizures?
  3. 3.How can we tell if my child’s nighttime wakings are due to a 'diminished need for sleep' or if they are being caused by untreated GERD or constipation?
  4. 4.What is the appropriate starting dose of melatonin for my child, and should we use an immediate-release or prolonged-release version?
  5. 5.Given the risk of low bone density, how often should my child have a DXA scan, and should we be monitoring their Vitamin D levels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Prevalence of gastrointestinal symptoms in Angelman syndrome.

    Glassman LW, Grocott OR, Kunz PA, et al.

    American journal of medical genetics. Part A 2017; (173(10)):2703-2709 doi:10.1002/ajmg.a.38401.

    PMID: 28816003
  2. 2

    Factors associated with sleep disturbances in children and adolescents with Angelman Syndrome.

    Leader G, Killeen C, Whelan S, et al.

    Sleep medicine 2024; (117()):9-17 doi:10.1016/j.sleep.2024.02.038.

    PMID: 38479041
  3. 3

    Angelman Syndrome: Multidisciplinary Management.

    Bridges WA, Temples HS, Lowe TB

    Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners 2025; (39(6)):968-975 doi:10.1016/j.pedhc.2025.06.005.

    PMID: 40643417
  4. 4

    Two siblings suffering from Angelman Syndrome with a novel c.1146T>G mutation in UBE3A: A case report.

    Liu C, Liu RH, Sun GF, et al.

    Biomedical reports 2022; (16(6)):48 doi:10.3892/br.2022.1531.

    PMID: 35620312
  5. 5

    [Epilepsy in Angelman syndrome and the most common electroencephalographic findings].

    Ebrat-Mancilla E, Sánchez-Aparicio A, Pérez de Vargas-Martínez A, et al.

    Revista de neurologia 2024; (79(8)):223-228 doi:10.33588/rn.7908.2024233.

    PMID: 39404036
  6. 6

    Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital.

    Shaaya EA, Grocott OR, Laing O, Thibert RL

    Epilepsy & behavior : E&B 2016; (60()):138-141 doi:10.1016/j.yebeh.2016.04.030.

    PMID: 27206232
  7. 7

    Exploring the Clinical and Genetic Landscape of Angelman Syndrome: Patient-Reported Insights from an Italian Registry.

    Carriero PL, Zangari R, Sfreddo E, et al.

    Journal of clinical medicine 2024; (13(12)) doi:10.3390/jcm13123520.

    PMID: 38930051
  8. 8

    Therapeutic approach to neurological manifestations of Angelman syndrome.

    Ascoli M, Elia M, Gasparini S, et al.

    Expert review of clinical pharmacology 2022; (15(7)):843-850 doi:10.1080/17512433.2022.2109463.

    PMID: 35917229
  9. 9

    Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital.

    Grocott OR, Herrington KS, Pfeifer HH, et al.

    Epilepsy & behavior : E&B 2017; (68()):45-50 doi:10.1016/j.yebeh.2016.12.018.

    PMID: 28109989
  10. 10

    Efficacy and tolerability of a low-glycemic-index ketogenic diet in Angelman syndrome: findings from the DIANE study.

    Iglesias Escalera G, Cazorla Calleja R, Lorenzo Ruiz M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):525 doi:10.1186/s13023-025-04037-z.

    PMID: 41121232
  11. 11

    Sleep in children with Angelman syndrome: Parental concerns and priorities.

    Trickett J, Heald M, Oliver C

    Research in developmental disabilities 2017; (69()):105-115 doi:10.1016/j.ridd.2017.07.017.

    PMID: 28844022
  12. 12

    Angelman syndrome and melatonin: What can they teach us about sleep regulation.

    Buonfiglio D, Hummer DL, Armstrong A, et al.

    Journal of pineal research 2020; (69(4)):e12697 doi:10.1111/jpi.12697.

    PMID: 32976638
  13. 13

    Maternal Ube3a Loss Disrupts Sleep Homeostasis But Leaves Circadian Rhythmicity Largely Intact.

    Ehlen JC, Jones KA, Pinckney L, et al.

    The Journal of neuroscience : the official journal of the Society for Neuroscience 2015; (35(40)):13587-98 doi:10.1523/JNEUROSCI.2194-15.2015.

    PMID: 26446213
  14. 14

    Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a.

    Shi SQ, Mahoney CE, Houdek P, et al.

    Frontiers in behavioral neuroscience 2022; (16()):837523 doi:10.3389/fnbeh.2022.837523.

    PMID: 35401134
  15. 15

    Melatonin Use in Pediatrics: A Clinical Review on Indications, Multisystem Effects, and Toxicity.

    Shenoy P, Etcheverry A, Ia J, et al.

    Children (Basel, Switzerland) 2024; (11(3)) doi:10.3390/children11030323.

    PMID: 38539358
  16. 16

    Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

    Besag FMC, Vasey MJ, Lao KSJ, Wong ICK

    CNS drugs 2019; (33(12)):1167-1186 doi:10.1007/s40263-019-00680-w.

    PMID: 31722088
  17. 17

    The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review.

    Rana M, Kothare S, DeBassio W

    Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent 2021; (30(1)):25-35.

    PMID: 33552170
  18. 18

    Direct assessment of overnight parent-child proximity in children with behavioral insomnia: Extending models of operant and classical conditioning.

    Agar G, Oliver C, Richards C

    Behavioral sleep medicine 2023; (21(3)):254-272 doi:10.1080/15402002.2022.2076681.

    PMID: 35796281
  19. 19

    Association between early and current gastro-intestinal symptoms and co-morbidities in children and adolescents with Angelman syndrome.

    Leader G, Whelan S, Chonaill NN, et al.

    Journal of intellectual disability research : JIDR 2022; (66(11)):865-879 doi:10.1111/jir.12975.

    PMID: 36052644
  20. 20

    Evidence-Based Clinical Guidelines for Chronic Constipation 2023.

    Ihara E, Manabe N, Ohkubo H, et al.

    Digestion 2025; (106(1)):62-89 doi:10.1159/000540912.

    PMID: 39159626
  21. 21

    An Evidence-Based Approach to the Treatment of Gastroesophageal Reflux Disease.

    Patti MG

    JAMA surgery 2016; (151(1)):73-8 doi:10.1001/jamasurg.2015.4233.

    PMID: 26629969
  22. 22

    Angelman syndrome in adolescence and adulthood: A retrospective chart review of 53 cases.

    Prasad A, Grocott O, Parkin K, et al.

    American journal of medical genetics. Part A 2018; (176(6)):1327-1334 doi:10.1002/ajmg.a.38694.

    PMID: 29696750
  23. 23

    The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

    Fan HC, Lee HS, Chang KP, et al.

    International journal of molecular sciences 2016; (17(8)).

    PMID: 27490534
  24. 24

    Quality in dual-energy X-ray absorptiometry scans.

    Morgan SL, Prater GL

    Bone 2017; (104()):13-28 doi:10.1016/j.bone.2017.01.033.

    PMID: 28159711

This page is for educational purposes only and does not replace professional medical advice. Always consult your child's neurologist or healthcare team before making changes to medications, diet, or sleep routines.

Get notified when new evidence is published on Angelman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.